Location History:
- Bayamon, PR (US) (2001)
- Rio Piedras, PR (US) (2002)
- San Juan, PR (US) (2013 - 2014)
Company Filing History:
Years Active: 2001-2014
Title: The Innovative Contributions of Vesna Ana Eterovic
Introduction
Vesna Ana Eterovic is a prominent inventor based in San Juan, Puerto Rico. She has made significant contributions to the field of medical research, particularly in the area of therapeutic applications against HIV and neuroinjury. With a total of 4 patents, her work has the potential to impact the lives of many individuals affected by these conditions.
Latest Patents
Eterovic's latest patents include groundbreaking methods and compositions aimed at combating HIV virus replication and associated neurocognitive disorders. One of her notable inventions focuses on the therapeutic application of cembranoids against HIV virus replication, specifically targeting HIV-1 virus strains. This method involves administering an effective amount of a macrocyclic diterpenoid, such as 4R cembranoid, to modulate the production and liberation of inflammatory mediators. Additionally, she has developed methods and compositions for protecting and treating neuroinjury, particularly from organophosphate-induced neuronal injury. This includes neuroprotective pharmaceutical compositions and a kit designed for protecting subjects from neurodamage.
Career Highlights
Throughout her career, Eterovic has worked with esteemed institutions, including the Morehouse School of Medicine. Her research has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
Eterovic has collaborated with notable colleagues such as Abimael D Rodriguez and Richard M Hann, contributing to a rich exchange of ideas and advancements in her field.
Conclusion
Vesna Ana Eterovic's contributions to medical research and her innovative patents highlight her dedication to improving health outcomes for individuals affected by HIV and neuroinjury. Her work exemplifies the impact of innovation in addressing critical health issues.